We then listed the top 10 mRNA molecules (NRF1, MAP1A, FOXJ3, NCOA1, RAB3C, NRP2, CCNT2, SP1, ZEB2, and RGMA) and compared their expression changes in NSCLC after treatment with miR-377 inhibitor. This evidence concerns the gene MAP1A and non-small cell lung carcinoma.